Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mulberry Twig Alkaloids vs Dapagliflozin in Type 2 Diabetes
ChiCTR2600117167Phase 4Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Mulberry Twig Total Alkaloids Tablets arm with Dapagliflozin arm (2 arms). Primary endpoints: Glycated hemoglobin (HbA1c) and Blood glucose variability index (including Time in Range, TIR). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ramulus mori alkaloidsdapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2600117167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117167.